Show simple item record

dc.contributor.authorDe Giorgi, Riccardo
dc.date.accessioned2022-06-23T14:08:24Z
dc.date.available2022-06-23T14:08:24Z
dc.date.issued2022-02
dc.identifier.citationRiccardo De Giorgi. Ketamine for suicidal ideation: New trial challenges current thinking about ketamine. BMJ 2022;376:o74en
dc.identifier.urihttps://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/1052
dc.descriptionOpen Accessen
dc.description.abstractWill ketamine be given to eligible patients with suicidal ideation any time soon? This is hard to say, given the plausible concern that the widespread use of ketamine might trigger a new opioid style crisis.10 Whether ketamine reduces suicidal ideation in some people is a matter of evidence —which this trial by Abbar and colleagues provides. But whether the emergency use of ketamine for suicidal crises will be recommended in practice depends on many other factors, including the values and preferences of patients, clinicians, researchers, and policymakers.en
dc.description.urihttps://doi.org/10.1136/bmj.o74en
dc.language.isoenen
dc.subjectSuicideen
dc.titleKetamine for suicidal ideation: New trial challenges current thinking about ketamineen
dc.typeArticleen
dc.contributor.disciplineMedical Traineeen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record